Science Explorer Back to mapMap
Discussion
Researcher · Tehran University of Medical Sciences · Iran

Alireza Esteghamati

Alireza Esteghamati publishes mostly in Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Adipokines, Inflammation, and Metabolic Diseases and Chronic Kidney Disease and Diabetes.

ORCID 0000-0001-5114-3982 OpenAlex
World rank
#166,681
of 7,710,434 ranked researchers
Rank in Iran
#758
of 71,317
Works
435
Citations
175k
Citations per work
402.0
h-index
75
i10-index 262Top 0.8% in Endocrinology, Diabetes and Metabolism
Alireza Esteghamati

What does Alireza Esteghamati research?

Alireza Esteghamati's work is mostly in Medicine (50%).

Everything else: 219 works · 50.3% of their workHealth Sciences: 216 works · 49.7% of their workMedicine: 216 works · 49.7% of their workEndocrinology, Diabetes and Metabolism: 92 works · 21.2% of their workEpidemiology: 40 works · 9.1% of their workCardiology and Cardiovascular Medicine: 24 works · 5.5% of their workPhysiology: 23 works · 5.2% of their workPublic Health, Environmental and Occupational Health: 20 works · 4.5% of their workNephrology: 18 works · 4.2% of their workTHEIR WORKAlirezaEsteghamati435works
Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else21950.3%
    1. Medicine21649.7%
  1. 1Endocrinology, Diabetes and Metabolism21% of their works
  2. 2Epidemiology9% of their works
  3. 3Cardiology and Cardiovascular Medicine6% of their works
  4. 4Physiology5% of their works
  5. 5Public Health, Environmental and Occupational Health4% of their works
  6. 6Nephrology4% of their works

Research topics

Which keywords describe Alireza Esteghamati's research?

The keywords of their largest research topics: Cardiovascular Disease, Insulin Resistance, Metabolic Syndrome, Obesity, Diabetes, Atherosclerosis, Glucose Metabolism and Type 2 Diabetes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 25 words, with their numbers
  1. Cardiovascular Disease2374 topics
  2. Insulin Resistance2013 topics
  3. Metabolic Syndrome2013 topics
  4. Obesity1772 topics
  5. Diabetes1673 topics
  6. Atherosclerosis1161 topic
  7. Glucose Metabolism1161 topic
  8. Type 2 Diabetes862 topics
  9. C-Reactive Protein842 topics
  10. Glycemic Control763 topics
  11. Adipose Tissue611 topic
  12. Inflammation611 topic
  13. Insulin Therapy512 topics
  14. Chronic Kidney Disease341 topic
  15. Glomerular Filtration Rate341 topic
  16. Continuous Glucose Monitoring261 topic
  17. Hypoglycemia261 topic
  18. Cardiovascular Outcomes251 topic
  19. Depression251 topic
  20. Glucose Control251 topic
  21. Self-Management251 topic
  22. NAFLD241 topic
  23. NASH241 topic
  24. Cholesterol-lowering231 topic
  25. Statins231 topic

Where does Alireza Esteghamati work?

Alireza Esteghamati's main affiliation in the publication record is Tehran University of Medical Sciences, Iran.

How many publications and citations does Alireza Esteghamati have?

OpenAlex counts 435 works and 174,864 citations for Alireza Esteghamati, an h-index of 75, ranking #166,681 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Alireza Esteghamati

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alireza Esteghamati. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.